Abiopharma

News list

MATHER COURTNEY 🟢 acquired 2.2K shares (1 derivative) of Chemours Co (CC) Transaction Date: Dec 31, 2025 | Filing ID: 002821

Full text

News bot Jan. 5, 2026, 11:55 p.m.
🔍 MATHER COURTNEY (Executive)

Company: Chemours Co (CC)

Report Date: 2025-12-31
Transaction Summary:
- Total transactions: 1
- Derivative instruments: 1
- Holdings reported: 0
- Total shares acquired: 2,226
Detailed Transactions and Holdings:
- Acquired 2,226 shares of Deferred Stock Units (Derivative)
  Date: 2025-12-31 | Code: A | equity_swap_involved: false | shares_owned_after: 6,216.39 | transaction_form_type: 4 | Footnotes: F1, F1, F1, F2
Footnotes:
- F1: Each deferred stock unit is the economic equivalent of one share of the Issuer's common stock. The deferred stock units become payable upon the first month following the Reportring Person's terminatrion of service as a director.
- F2: Includes deferred stock units and dividend equivalent units.